#sandiegosymphony
We cordially invite you to join the San Diego Symphony for Discovery Night, honoring Daniel Bradbury for his remarkable contributions to the life sciences community.
The celebration will take place at the Jacobs Music Center, with proceeds from this event supporting the Symphony’s Learning and Community Engagement initiatives.
Invite friends and colleagues to enjoy an elegant pre-concert reception at The University Club, where guests will enjoy cocktails, wine, and hearty appetizers. The evening continues with a special performance by acclaimed Broadway conductor and arranger Rob Fisher, featuring an evening of songs from George and Ira Gershwin performed by Broadway stars. Keep the energy going after the show in the Jacobs Music Center lobby, where a selection of desserts and a cash bar await, perfect for mingling, connecting, and celebrating the evening with fellow guests!
5:30PM
Pre-Concert Cocktail Reception
THE UNIVERSITY CLUB
6:30PM
Remarks in Honor of Daniel Bradbury
THE UNIVERSITY CLUB
7:30PM
"The Gershwins on Broadway" Concert led by Rob Fisher
JACOBS MUSIC CENTER'S MILLER FAMILY STAGE
$25,000: Positioning as a Presenting Sponsor of Discovery Night 2026
***************************
$10,000: Recognition as a Lead Sponsor of Discovery Night 2026
***************************
$5,000: Recognition as a Proud Sponsor of Discovery Night 2026
***************************
$2,500: Positioning as a Proud Sponsor of Discovery Night 2026
$500 Premier Ticket:
***************************
$350 Preferred Ticket:
*Subject to availability
I WOULD LIKE TO SPONSOR OR RESERVE A TICKET TO THIS EVENT
If you would like to discuss sponsorship opportunities or require further information,
please contact Special Events at SpecialEvents@SanDiegoSymphony.org or 619.615.3906.
I CANNOT ATTEND, BUT I WOULD LIKE TO HONOR DANIEL BRADBURY WITH A CONTRIBUTION
Dan Bradbury is a Life Sciences Executive with over 40 years of experience creating and implementing strategies that transform businesses, bring novel medicines to market, and maximize shareholder value. He is the Managing Member of BioBrit, LLC, a Life Sciences Consulting and Investment Firm based in La Jolla, CA.
Dan is the Chairman and Co-Founder of Equillium, Inc. (NASDAQ: EQ), a publicly traded biopharmaceutical company based in La Jolla, CA, focused on developing products to treat severe autoimmune and inflammatory disorders with high unmet medical need. He served as Executive Chairman until October 2025 and Chief Executive Officer until January 2020. He is the former President, Chief Executive Officer, and Director of Amylin Pharmaceuticals, a biopharmaceutical company based in San Diego, CA, focused on metabolic diseases. During his 18-year tenure at Amylin, the company launched three first-in-class medicines, including the first once-a-week therapy to treat diabetes, and was listed on the Nasdaq 100. He served as Amylin’s Chief Executive Officer from March 2007 until its acquisition by Bristol-Myers Squibb Company in August 2012. Before joining Amylin, Dan worked in marketing and sales roles for ten years at SmithKline Beecham Pharmaceuticals.
Dan serves on the board of directors of Castle Biosciences, Inc. (NASDAQ: CSTL), Equillium, Inc. (NASDAQ: EQ), Vivani Medical, Inc. (NASDAQ: VANI) and a number of private companies and philanthropic organizations.
Dan received a Bachelor of Pharmacy from Nottingham University and a Diploma in Management Studies from the University of West London in the United Kingdom.
FOR TICKET SERVICE E-MAIL
TICKETS@SANDIEGOSYMPHONY.ORG